Compare · TMO vs VICR
TMO vs VICR
Side-by-side comparison of Thermo Fisher Scientific Inc (TMO) and Vicor Corporation (VICR): market cap, price performance, sector, and recent activity on the wire.
Summary
- TMO operates in Industrials, while VICR operates in Technology - the two are in different parts of the market.
- TMO is the larger of the two at $197.88B, about 18.3x VICR ($10.83B).
- Over the past year, TMO is up 30.5% and VICR is up 391.7% - VICR leads by 361.2 points.
- VICR has been more active in the news (13 items in the past 4 weeks vs 7 for TMO).
- TMO has more recent analyst coverage (25 ratings vs 13 for VICR).
- Company
- Thermo Fisher Scientific Inc
- Vicor Corporation
- Price
- $528.74-0.64%
- $235.08-1.18%
- Market cap
- $197.88B
- $10.83B
- 1M return
- +14.53%
- -27.72%
- 1Y return
- +30.52%
- +391.70%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 7
- 13
- Recent ratings
- 25
- 13
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Vicor Corporation
Vicor Corporation, together with its subsidiaries, designs, develops, manufactures, and markets modular power components and power systems for converting electrical power in the United States, Europe, the Asia Pacific, and internationally. The company offers a range of brick-format DC-DC converters; complementary components; and input and output voltage, and output power products, as well as electrical and mechanical accessories. It also provides custom power systems solutions. The company serves independent manufacturers of electronic devices, original equipment manufacturers, and their contract manufacturers in the aerospace and aviation, defense electronics, industrial automation and equipment, instrumentation, test equipment, solid state lighting, telecommunications and networking infrastructure, and vehicles and transportation markets. Vicor Corporation was founded in 1981 and is headquartered in Andover, Massachusetts.
Latest TMO
- Thermo Fisher Scientific Announces Quarterly Dividend
- Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, July 23, 2026
- SEC Form 4 filed by Director Sperling Scott M
- SEC Form 4 filed by Director Keith R. Alexandra
- SEC Form 4 filed by Director Weisler Dion J
- SEC Form 4 filed by Director Lynch Karen S
- SEC Form 4 filed by Director Johnson Jennifer M
- Bernstein resumed coverage on Thermo Fisher with a new price target
- SEC Form 11-K filed by Thermo Fisher Scientific Inc
- Piper Sandler initiated coverage on Thermo Fisher with a new price target
Latest VICR
- SEC Form SCHEDULE 13G filed by Vicor Corporation
- Vicor Corporation to Hold Second Quarter Earnings Conference Call and Webcast on July 21, 2026
- Chairman & CEO Vinciarelli Patrizio sold $211,681 worth of shares (700 units at $302.40) as part of a pre-agreed trading plan, decreasing direct ownership by 0.01% to 8,347,390 units (SEC Form 4)
- Chairman & CEO Vinciarelli Patrizio sold $6,377,606 worth of shares (20,000 units at $318.88) as part of a pre-agreed trading plan, decreasing direct ownership by 0.24% to 8,348,090 units (SEC Form 4)
- Corp. VP-Global Sales & Mktg. Davies Philip D exercised 3,073 shares at a strike of $33.33 and sold $1,096,968 worth of shares (3,073 units at $356.97) as part of a pre-agreed trading plan (SEC Form 4)
- Chairman & CEO Vinciarelli Patrizio sold $7,133,640 worth of shares (20,000 units at $356.68) as part of a pre-agreed trading plan, decreasing direct ownership by 0.24% to 8,368,090 units (SEC Form 4)
- Chairman & CEO Vinciarelli Patrizio sold $7,500,832 worth of shares (20,000 units at $375.04) as part of a pre-agreed trading plan, decreasing direct ownership by 0.24% to 8,388,090 units (SEC Form 4)
- Chairman & CEO Vinciarelli Patrizio sold $3,214,709 worth of shares (8,760 units at $366.98) as part of a pre-agreed trading plan, decreasing direct ownership by 0.10% to 8,408,090 units (SEC Form 4)
- Chairman & CEO Vinciarelli Patrizio sold $3,878,212 worth of shares (11,240 units at $345.04) as part of a pre-agreed trading plan, decreasing direct ownership by 0.13% to 8,416,850 units (SEC Form 4)
- CFO, Treasurer, Secretary Schmidt James F exercised 1,000 shares at a strike of $100.00 and sold $331,681 worth of shares (1,000 units at $331.68) as part of a pre-agreed trading plan (SEC Form 4)